Key result
High ventricular ectopic burden is linked to a ~3-fold increase in major cardiovascular events risk.
Why the study?
The independent long-term prognostic significance of atrial and ventricular ectopy in low-risk populations without structural heart disease remains a subject of ongoing clinical debate.
Does high atrial or ventricular ectopic burden predict major adverse cardiovascular events in asymptomatic adults without structural heart disease?
Cohort (n=931)
No
Does high atrial or ventricular ectopic burden predict major adverse cardiovascular events in asymptomatic adults without structural heart disease?
In asymptomatic adults without structural heart disease, high ventricular ectopic burden is a strong independent predictor of long-term cardiovascular events, whereas atrial ectopic burden is not independently prognostic after adjusting for clinical factors and medications.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“These findings are a powerful reminder that the heart often whispers before it shouts. Subtle signs, such as frequent irregular heartbeats and complex arrhythmias, give us an early warning of future risk before symptoms occur. This could allow early intervention to alter the trajectory of disease, allowing us to move to a new era of anticipatory heart medicine.”
“Our findings suggest that risk of arrhythmia begins to increase well before typical retirement age. They strongly support the need to screen older adults for arrhythmias, beginning at around age 50, to allow for timely intervention and improved long-term outcomes.”
High VEB may flag elevated MACE risk in asymptomatic adults without SHD; this Level 3 association leaves open whether screening or intervention changes outcomes.
Background Atrial and ventricular ectopy are frequently encountered during ambulatory monitoring in asymptomatic adults; however, their independent long-term prognostic significance in low-risk populations without structural heart disease remains a subject of ongoing clinical debate. Purpose To identify the distinct clinical and physiological determinants of atrial ectopic burden (AEB) and ventricular ectopic burden (VEB), and to evaluate their independent long-term associations with major adverse cardiovascular events (MACE) in a primary prevention cohort. Methods We evaluated 931 asymptomatic individuals (mean age 52 ± 7 years; 13% female) without structural heart disease who completed a baseline 24-hour Holter recording. High AEB and VEB were defined using cohort-specific medians and/or the presence of ambulatory arrhythmic complexity. Complete longitudinal tracking for MACE (composite of acute coronary syndrome, cerebrovascular accident, new-onset heart failure or cardiovascular mortality) was available for 840 participants over a median follow-up of 8 years (IQR 5-11 years). To evaluate the robustness of the atrial findings, a prespecified sensitivity analysis was performed by excluding patients with baseline atrial fibrillation (AF). Results Over the follow-up period, the primary MACE endpoint occurred in 149 (18%) participants. In multivariable logistic regression models, high AEB was independently driven by older age (OR 1.09, 95% CI 1.06-1.12; p < 0.001), male sex (OR 1.60, 95% CI 1.02-2.52; p = 0.042), reduced eGFR (OR 0.98, 95% CI 0.97-0.99; p = 0.049), and low cardiorespiratory fitness (OR 1.38, 95% CI 1.01-1.92; p = 0.049). Conversely, high VEB was independently associated only with older age (OR 1.04, 95% CI 1.02-1.07; p < 0.001) and reduced eGFR (OR 0.98, 95% CI 0.97-0.99; p = 0.034). In fully adjusted multivariable Cox proportional hazards models, high VEB remained a robust independent predictor of MACE, conferring a three-fold increase in risk (HR 3.06, 95% CI 2.06-4.56; p < 0.001). In tertile-based analyses of pure ectopic burden, increasing VEB demonstrated a robust graded association with MACE after adjustment for age, sex, beta-blocker use and antiarrhythmic drug therapy (HR per tertile increase 2.02, 95% CI 1.60-2.53; p < 0.001), whereas AEB showed only a borderline association that did not reach statistical significance (HR per tertile increase 1.21, 95% CI 0.98-1.50; p = 0.076). Conclusion In asymptomatic adults without structural heart disease, the clinical determinants and long-term prognostic trajectories of ectopy exhibit a profound chamber-specific divergence. Ventricular ectopic burden stands out as a powerful, independent marker of intrinsic electrical vulnerability and long-term cardiovascular risk. Meanwhile, atrial ectopy is highly sensitive to systemic physiological fitness and carries a weaker prognostic signal that attenuates completely upon multivariate clinical and medication adjustment.
No takes yet. Share an insight, caveat, or question.
Moses et al. (2026) conducted a cohort in Asymptomatic adults without structural heart disease (n=931). High ventricular ectopic burden vs. Low ventricular ectopic burden was evaluated on Major adverse cardiovascular events (MACE), a composite of acute coronary syndrome, cerebrovascular accident, new-onset heart failure, or cardiovascular mortality (HR 3.06, 95% CI 2.06-4.56, p=<0.001). High ventricular ectopic burden independently predicted major adverse cardiovascular events in asymptomatic adults without structural heart disease, conferring a three-fold increase in risk.
Synapse has enriched 10 related papers. Consider them for comparative context: